News | Mente

Neurotech secures a new European commercial agreement with Brain Therapeutics in Greece as Mente Autism therapy distribution partner

by Mente Team | Sep 7, 2020 | News

News and Press Releases Neurotech secures a new European commercial agreement with Brain Therapeutics in Greece as Mente Autism therapy distribution partner Perth, Australia, Malta & Athens, Greece – Neurotech International Limited (ASX: NTI) (“Neurotech”...

Neurotech International’s At Home Therapy Device Mente receives CE mark renewal for use with ASD Children

by Mente Team | Apr 14, 2020 | News

News and Press Releases Neurotech International’s At Home Therapy Device Mente receives CE mark renewal for use with ASD Children Neurotech International Limited (ASX: NTI) (“Neurotech” or the “Company”), developer of quality medical solutions in the neuroscience...

Mente, the world’s only clinically proven stay at home therapy for ASD children, continues to build awareness in Europe

by Mente Team | Mar 30, 2020 | News

News and Press Releases Mente, the world’s only clinically proven stay at home therapy for ASD children, continues to build awareness in Europe Neurotech International Limited (ASX: NTI) is pleased to announce it has now been added to the UK’s National Autistic...

New Mente autism therapy referral program

by Mente Team | Feb 25, 2020 | News

News and Press Releases New Mente autism therapy referral program Malta and Perth, Australia – Neurotech International Limited (ASX: NTI) is pleased to announce an innovative clinic led initiative, being a new referral model that provides each Mente clinic with...

Neurotech Announces Mente Partnership with the Australian Neurofeedback Institute

by Mente Team | Dec 19, 2019 | News

News and Press Releases Neurotech Announces Mente Partnership with the Australian Neurofeedback Institute New qEEG service enhances support for clinics using or recommending Mente in Australia Malta and Perth, Australia – Neurotech International Limited (ASX:...

Neurotech signs exclusive agreement with Holy Stone Healthcare expanding distribution of Mente and support for children with autism in Taiwan

by Mente Team | Dec 19, 2019 | News

News and Press Releases Neurotech signs exclusive agreement with Holy Stone Healthcare expanding distribution of Mente and support for children with autism in Taiwan Malta and Perth, Australia – Neurotech International Limited (ASX: NTI) is pleased to announce...

Neurotech secures a new European commercial agreement with Brain Therapeutics in Greece as Mente Autism therapy distribution partner

Neurotech International’s At Home Therapy Device Mente receives CE mark renewal for use with ASD Children

Mente, the world’s only clinically proven stay at home therapy for ASD children, continues to build awareness in Europe

New Mente autism therapy referral program

Neurotech Announces Mente Partnership with the Australian Neurofeedback Institute

Neurotech signs exclusive agreement with Holy Stone Healthcare expanding distribution of Mente and support for children with autism in Taiwan

Recent Posts

Recent Comments

Archives

Categories

Meta

Please notify when Mente Medical is back in stock

Thanks for your details!

Find a Clinician

Thank you for your interest!

Thank you for your interest!

Thanks for contacting us!

Mente Premium Content

Mente Premium Content

Thank you for your interest in Mente!

Mente E-Book

Thank you for taking the time to answer this survey!

Thank you for your interest!

Login to your Mente Dashboard